Last updated: 19 June 2019 at 3:29am EST

Stephen T Reeders Net Worth




The estimated Net Worth of Stephen T Reeders is at least 4.67 百万$ dollars as of 27 February 2006. Stephen Reeders owns over 242,466 units of Momenta Pharmaceuticals stock worth over 413,542$ and over the last 20 years Stephen sold MNTA stock worth over 4,260,128$.

Stephen Reeders MNTA stock SEC Form 4 insiders trading

Stephen has made over 1 trades of the Momenta Pharmaceuticals stock since 2006, according to the Form 4 filled with the SEC. Most recently Stephen sold 242,466 units of MNTA stock worth 4,260,128$ on 27 February 2006.

The largest trade Stephen's ever made was selling 242,466 units of Momenta Pharmaceuticals stock on 27 February 2006 worth over 4,260,128$. On average, Stephen trades about 34,638 units every 0 days since 2004. As of 27 February 2006 Stephen still owns at least 7,880 units of Momenta Pharmaceuticals stock.

You can see the complete history of Stephen Reeders stock trades at the bottom of the page.



What's Stephen Reeders's mailing address?

Stephen's mailing address filed with the SEC is C/O MOMENTA PHARMACEUTICALS, INC., 43 MOULTON STREET, CAMBRIDGE, MA, 02138.

Insiders trading at Momenta Pharmaceuticals

Over the last 20 years, insiders at Momenta Pharmaceuticals have traded over 110,027,424$ worth of Momenta Pharmaceuticals stock and bought 827,300 units worth 5,505,611$ . The most active insiders traders include Christoph H WestphalCraig A WheelerPeter Barrett. On average, Momenta Pharmaceuticals executives and independent directors trade stock every 6 days with the average trade being worth of 448,442$. The most recent stock trade was executed by Ian Fier on 20 August 2020, trading 1,808 units of MNTA stock currently worth 94,323$.



What does Momenta Pharmaceuticals do?

Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.



Complete history of Stephen Reeders stock trades at Momenta Pharmaceuticals

インサイダー
取引
取引
合計金額
Stephen T Reeders
ディレクター
販売 4,260,128$
27 Feb 2006


Momenta Pharmaceuticals executives and stock owners

Momenta Pharmaceuticals executives and other stock owners filed with the SEC include: